Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional ...

says Siow Ming Lee, a medical oncologist at University College London, who is leading a clinical trial of an mRNA vaccine for lung cancer patients.

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...